Acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
subsequent	subsequent	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
rifampicin	rifampicin	O	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
follow-up	follow-up	O	O	O	O
study	study	O	O	O	O
of	of	O	O	O	O
cases	cases	O	O	O	O
reported	reported	O	O	O	O
earlier	earlier	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
clinical	clinical	O	O	O	O
presentation	presentation	O	O	O	O
is	is	O	O	O	O
made	made	O	O	O	O
of	of	O	O	O	O
a	a	O	O	O	O
2	2	O	O	O	O
-	-	O	O	O	O
3	3	O	O	O	O
year	year	O	O	O	O
follow-up	follow-up	O	O	O	O
of	of	O	O	O	O
six	six	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
acute	acute	O	DISEASE	OTHERS	I
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
that	that	O	O	O	O
have	have	O	O	O	O
been	been	O	O	O	O
reported	reported	O	O	O	O
earlier	earlier	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
patients	patients	O	O	O	O
had	had	O	O	O	O
developed	developed	O	O	O	O
transient	transient	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
after	after	O	O	O	O
the	the	O	O	O	O
intermittent	intermittent	O	O	O	O
administration	administration	O	O	O	O
of	of	O	O	O	O
rifampicin	rifampicin	O	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
stage	stage	O	O	O	O
of	of	O	O	O	O
olig-anuria	olig-anuria	O	O	O	O
lasted	lasted	O	O	O	O
for	for	O	O	O	O
1	1	O	O	O	O
-	-	O	O	O	O
3	3	O	O	O	O
weeks	weeks	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
five	five	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
were	were	O	O	O	O
treated	treated	O	O	O	O
by	by	O	O	O	O
hemodialysis	hemodialysis	O	O	O	O
.	.	O	O	O	O

Two	two	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
patients	patients	O	O	O	O
died	died	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
unrelated	unrelated	O	O	O	O
causes	causes	O	O	O	O
during	during	O	O	O	O
the	the	O	O	O	O
follow-up	follow-up	O	O	O	O
period	period	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
four	four	O	O	O	O
patients	patients	O	O	O	O
re-examined	re-examined	O	O	O	O
were	were	O	O	O	O
clinically	clinically	O	O	O	O
cured	cured	O	O	O	O
.	.	O	O	O	O

Pathologic	pathologic	O	O	O	O
findings	findings	O	O	O	O
by	by	O	O	O	O
light	light	O	O	O	O
microscopy	microscopy	O	O	O	O
and	and	O	O	O	O
immunofluorescence	immunofluorescence	O	O	O	O
at	at	O	O	O	O
biopsy	biopsy	O	O	O	O
were	were	O	O	O	O
scarce	scarce	O	O	O	O
.	.	O	O	O	O

Nothing	nothing	O	O	O	O
abnormal	abnormal	O	O	O	O
was	was	O	O	O	O
seen	seen	O	O	O	O
by	by	O	O	O	O
electron	electron	O	O	O	O
microscopy	microscopy	O	O	O	O
in	in	O	O	O	O
two	two	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
cases	cases	O	O	O	O
studied	studied	O	O	O	O
.	.	O	O	O	O

Renal	renal	O	O	O	O
function	function	O	O	O	O
was	was	O	O	O	O
normal	normal	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
three	three	O	O	O	O
cases	cases	O	O	O	O
the	the	O	O	O	O
excretion	excretion	O	O	O	O
at	at	O	O	O	O
131I-hippuran	131i-hippuran	O	O	O	O
renography	renography	O	O	O	O
was	was	O	O	O	O
slightly	slightly	O	O	O	O
slowed	slowed	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
acute	acute	O	O	O	O
stage	stage	O	O	O	O
the	the	O	O	O	O
renal	renal	O	O	OTHERS	I
lesions	lesions	O	O	OTHERS	I
histologically	histologically	O	O	O	O
appeared	appeared	O	O	O	O
toxic	toxic	O	O	O	O
,	,	O	O	O	O
evidence	evidence	O	O	O	O
suggestive	suggestive	O	O	O	O
of	of	O	O	O	O
an	an	O	O	O	O
immunological	immunological	O	O	O	O
mechanism	mechanism	O	O	O	O
can	can	O	O	O	O
not	not	O	O	O	O
be	be	O	O	O	O
excluded	excluded	O	O	O	O
.	.	O	O	O	O

